Inotiv | analyze. answer. advance.
  • About
    • Why Inotiv
    • Leadership
    • News
    • Events
    • Regulatory Compliance
    • Our Commitment to Integrity and Ethical Conduct
  • Services
    • Research and Discovery
      • Computational Toxicology
      • Disease Pharmacology (in vitro and in vivo)
      • DMPK (in vitro and in vivo)
      • Safety Pharmacology
      • Cell and Molecular Biology
      • Discovery Bioanalysis
        • Biomarkers
      • Exploratory Toxicology
        • Toxicogenomics
        • Genetic Toxicology
        • General Toxicology
      • Surgical Models and Medical Device
    • Nonclinical Safety Assessment
      • General Toxicology
      • Safety Pharmacology
      • Genetic Toxicology
      • Regulated Bioanalysis
      • — Biotherapeutics
        • Biomarker
      • DMPK (PK/TK)
      • Developmental and Reproductive Toxicology
      • Carcinogenicity Studies
      • Surgical Models and Medical Device
    • Pathology
      • Histology
      • Digital Pathology
      • Clinical Pathology
      • Medical Device Pathology
    • Bioanalysis
      • Nonregulated Discovery Bioanalysis
      • Regulated Preclinical and Clinical Bioanalysis
      • Biotherapeutics
        • Biomarkers
    • Proteomics
    • Consulting
    • Research Models and Services
  • Insights
  • Contact
  • |
  • Investors
  • Careers
  • VISIT OUR VIRTUAL BOOTH

2021

Financial News

December 16, 2021

Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results

Financial News

December 13, 2021

Inotiv, Inc. Reschedules Fourth Quarter Fiscal 2021 Financial Results and Conference Call for Thursday, December 16, 2021

Corporate News

December 13, 2021

Inotiv, Inc. Announces the Launch of New Genetically Engineered Rodent Models for SARS-CoV-2 (COVID-19) Research

Financial News

December 7, 2021

Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Fiscal 2021

Financial News

November 29, 2021

Inotiv, Inc. to Report Fourth Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, December 7, 2021

Corporate News

November 10, 2021

Inotiv, Inc. Announces Opening of Newly-Constructed Laboratories at St. Louis Facility

Corporate News

November 5, 2021

Inotiv, Inc. Completes Purchase of Envigo

Financial News

November 5, 2021

Inotiv, Inc. Shareholders Approve Acquisition of Envigo

Financial News

November 2, 2021

Inotiv, Inc. to Participate in Upcoming Investor Conferences

Corporate News

October 4, 2021

Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.

Posts navigation

Older posts
Get the Insights You Deserve

Answering the right questions on time and with high-quality data is the key to achieving your objectives. Expect more.

Get In Touch
Inotiv Logo

2701 Kent Avenue
West Lafayette, IN 47906 USA
800.845.4246
765.463.4527

Copyright © 2023 Inotiv. All Rights Reserved.

  • Privacy
  • Accessibility
  • Terms Of Use
  • Contact
  • About
    • Why Inotiv
    • Leadership
    • News
    • Events
    • Regulatory Compliance
    • Our Commitment to Integrity and Ethical Conduct
  • Services
    • Research and Discovery
      • Computational Toxicology
      • Disease Pharmacology (in vitro and in vivo)
      • DMPK (in vitro and in vivo)
      • Safety Pharmacology
      • Cell and Molecular Biology
      • Discovery Bioanalysis
        • Biomarkers
      • Exploratory Toxicology
        • Toxicogenomics
        • Genetic Toxicology
        • General Toxicology
      • Surgical Models and Medical Device
    • Nonclinical Safety Assessment
      • General Toxicology
      • Safety Pharmacology
      • Genetic Toxicology
      • Regulated Bioanalysis
      • — Biotherapeutics
        • Biomarker
      • DMPK (PK/TK)
      • Developmental and Reproductive Toxicology
      • Carcinogenicity Studies
      • Surgical Models and Medical Device
    • Pathology
      • Histology
      • Digital Pathology
      • Clinical Pathology
      • Medical Device Pathology
    • Bioanalysis
      • Nonregulated Discovery Bioanalysis
      • Regulated Preclinical and Clinical Bioanalysis
      • Biotherapeutics
        • Biomarkers
    • Proteomics
    • Consulting
    • Research Models and Services
  • Insights
  • Contact
  • |
  • Investors
  • Careers
  • VISIT OUR VIRTUAL BOOTH